First Dallas Securities Inc. Moderna, Inc. Transaction History

First Dallas Securities Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	SELL	$118.5 - $160.53 $154,050 - $208,689	-1,300 Reduced 42.98%	1,725 $210,000
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $217,056 - $315,232	-1,600 Reduced 34.59%	3,025 $465,000
Q4 2022 Feb 03, 2023	BUY	$118.38 - $210.04 $325,545 - $577,610	2,750 Added 146.67%	4,625 $831,000
Q1 2022 May 12, 2022	BUY	$126.46 - $235.05 $1,264 - $2,350	10 Added 0.54%	1,875 $323,000
Q4 2021 Feb 07, 2022	SELL	$225.82 - $368.51 $11,291 - $18,425	-50 Reduced 2.61%	1,865 $474,000
Q3 2021 Oct 06, 2021	SELL	$221.9 - $484.47 $274,046 - $598,320	-1,235 Reduced 39.21%	1,915 $737,000
Q2 2021 Jul 06, 2021	BUY	$129.91 - $234.98 $409,216 - $740,187	3,150 New	3,150 $740,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of First Dallas Securities Inc., based on Form 13F filings with the SEC.

Stay updated on First Dallas Securities Inc. with notifications on news.